NCT06163092 Chronic Endometritis and Benefits of Antibiotics in Women With Recurrent Miscarriage
| NCT ID | NCT06163092 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Recurrent Miscarriage |
| Study Type | OBSERVATIONAL |
| Enrollment | 175 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 175 participants in total. It began in 2024-04-01 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to estimate the incidence of CE, evaluate the endometrial microorganism of CE, and investigate the therapeutic benefits of antibiotics for women with unexplained recurrent miscarriage and CE.
Eligibility Criteria
Inclusion Criteria: * Women with a history of 2 or more consecutive miscarriages before 24 weeks of gestation * Women aged 20-45 years old Exclusion Criteria: * Uncorrected uterine anomalies, such as the septate or bicornuate uterus, fibroids (submucous/intramural) * Untreated hydrosalpinx * Antiphospholipid syndrome * Known clinical autoimmune disease * Undergoing immunotherapy * Abnormal thyroid function * Abnormal karyotyping of couples * Known immunodeficiency pathologies such as diabetes or HIV * Currently taking other antibiotics or other trial medications or TCM; * Currently or previously involved in other clinical trials with medication intake; * Those with active pelvic inflammatory disease or suspicion of infection etc.
Contact & Investigator
Jacqueline Pui Wah Chung, MBBS
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT06163092 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Recurrent Miscarriage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06163092 currently recruiting?
Yes, NCT06163092 is actively recruiting participants. Contact the research team at staceywong@cuhk.edu.hk for enrollment information.
Where is the NCT06163092 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06163092 clinical trial?
NCT06163092 is sponsored by Chinese University of Hong Kong. The principal investigator is Jacqueline Pui Wah Chung, MBBS at Chinese University of Hong Kong. The trial plans to enroll 175 participants.